Insulet Corp at Robert W Baird Global Healthcare Conference Transcript
Good afternoon. I think we're going to get started. My name is Jeff Johnson. I'm the senior medical technology analyst at Baird and our next presentation this afternoon is from Insulet Corporation, a leader in the $3.5 billion global insulin pump market.
With us today from Insulet, we're happy to have Chief Executive Officer, Jim Hollingshead, Chief Financial Officer, Wayde McMillan and Vice President of Investor Relations, Deb Gordon. Jim, I'm going to turn it over to you if you have a few minutes of prepared remarks, and then we'll go into Q&A.
Thanks, Jeff, and thanks for having us, and thanks for coming everybody. Our business has just fantastic momentum. We're coming off of a record quarter with our Q2. We had record new customer starts, a really terrific new customer starts quarter. We grew 32% globally, which is our largest growth number since 2019, and we're a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
